Kiadis merges with the Canadian Celmed BioSciences

Kiadis B.V, a Dutch early product development company, and Celmed BioSciences Inc., a Canadian clinical product development company, have agreed to merge both oncology-focused companies. The combined company will be named Kiadis Pharma B.V. and headquartered in the Netherlands with facilities in the Netherlands and Canada.

Stibbe advised Kiadis and its major shareholder Life Sciences Partners in this transaction.